Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dynamic Matrisome: ECM Remodeling Factors Licensing Cancer Progression and Metastasis

Journal article

yuzhalin A. et al, (2018), Biochimica et Biophysica Acta (BBA) - Reviews on Cancer


Conference paper

Jones K. et al, (2018), BRITISH JOURNAL OF SURGERY, 105, 45 - 46

A core matrisome gene signature predicts cancer outcome.

Journal article

Yuzhalin AE. et al, (2018), Br J Cancer, 118, 435 - 440

Reply to 'Comment on 'A meta-analysis of CXCL12 expression for cancer prognosis".

Journal article

Gordon-Weeks A., (2018), Br J Cancer, 118

Acalculous Cholecystitis: Is an Elective Interval Cholecystectomy Necessary

Journal article

Abbas SH. et al, (2018), Digestive Surgery, 35, 171 - 176

Possible congenital dilatation of the pancreatic duct.

Journal article

Tavare A. et al, (2017), BMJ Case Rep, 2017

Surgeons opinions of legal practice in bile duct injury following cholecystectomy.

Journal article

Gordon-Weeks A. et al, (2017), HPB (Oxford), 19, 721 - 726

A meta-analysis of CXCL12 expression for cancer prognosis.

Journal article

Samarendra H. et al, (2017), Br J Cancer, 117, 124 - 135

Neutrophils promote hepatic metastasis growth through fibroblast growth factor 2-dependent angiogenesis in mice.

Journal article

Gordon-Weeks AN. et al, (2017), Hepatology, 65, 1920 - 1935

Targeting the CCL2-CCR2 signaling axis in cancer metastasis.

Journal article

Lim SY. et al, (2016), Oncotarget, 7, 28697 - 28710

Macrophage migration inhibitory factor: A key cytokine and therapeutic target in colon cancer

Journal article

Gordon-Weeks AN. et al, (2015), Cytokine and Growth Factor Reviews, 26, 451 - 461

Load More